Search bioRxiv⌕ Search

Biology subjects

Quaye, C.

Publications and source records attributed to Quaye, C..

3 recordsLinked to original sources

Exposure to a low dose mixture of endocrine disrupting chemicals alters the brain transcriptome and animal behavior

Exposures to pervasive chemical toxicants such as endocrine disrupting chemicals (EDCs) are associated with adverse neurological and neurodevelopmental deficits. Although EDCs are widespread as sparse mixtures in the environment, most research has focused on single chemicals at high concentrations. Here, we studied the effects of ldEDC: a low-dose mixture of widely prevalent toxicants at doses representative of normal human exposure levels. Primary cultured mouse neurons treated with ldEDC exhibited altered gene expression compared to vehicle controls in genes critical for neuron activity, indicating low doses EDCs can affect neuronal function directly. We next tested persistent exposure through the maternal diet to define perinatal effects on offspring. Exposed offspring exhibited differences in development, tactile sensitivity, and sex-specific changes in motor behavior. Cortical single-nuclei sequencing identified broad transcriptomic changes, particularly in distinct cortical layer subpopulations, excitatory neurons, and astrocytes. Cell-cell signaling between neurons and non-neuronal populations were altered in exposed mice, specifically in pathways associated with cellular adhesion. Transcriptomic differences were also sex-specific. Together, these in vitro and in vivo findings reveal molecular and phenotypic consequences of EDC exposure at a mixture of doses well below commonly studied levels and highlights common functional pathways of susceptibility.

neuroscience↗

Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoprotein

Lassa fever is a severe, often fatal febrile illness endemic to West Africa caused by Lassa virus (LASV). The viral nucleoprotein (NP) is a target antigen for serological assays to identify previous exposure to LASV. To our knowledge, there is no commercially available assay that reliably quantifies anti-LASV-NP IgG antibodies in human serum. We report the development and qualification of an ELISA designed to detect and quantify anti-LASV-NP IgG in human serum samples. The assay employs recombinant Lineage IV LASV-NP immobilized on microwells to capture NP-specific IgG antibodies, which are then detected using horseradish peroxidase-conjugated anti-human IgG followed by TMB substrate and reading of optical densities. Optimal assay reagent concentrations, incubation times and temperature were determined along with assay positivity criteria and dynamic range. A reference standard prepared from pooled sera from donors in endemic Lassa fever regions was established and calibrated to the first WHO international standard for LASV antibodies. High and low positive controls for assay quality control were generated. Naive human serum was used as a negative control. Following assay optimization, performance was assessed through assay qualification. The assay positivity criteria, lower limit of detection, upper and lower limits of quantitation, inter-assay precision, selectivity and dilutional linearity were determined. Our anti-LASV-NP IgG ELISA was shown to reliably measure anti-LASV-NP IgG levels in human serum. The method demonstrated sensitivity, intra- and inter-assay precision, dilution linearity across its analytical range and specificity for anti-LASV-NP IgG. Establishing this assay represents an essential step toward strengthening LASV epidemiology research and supporting urgently needed development of a vaccine to prevent Lassa Fever.

immunology↗

Histone variant H2BE enhances chromatin accessibility in neurons to promote synaptic gene expression and long-term memory

Regulation of histone proteins affects gene expression through multiple mechanisms including exchange with histone variants. However, widely expressed variants of H2B remain elusive. Recent findings link histone variants to neurological disorders, yet few are well studied in the brain. We applied new tools including novel antibodies, biochemical assays, and sequencing approaches to reveal broad expression of the H2B variant H2BE, and defined its role in regulating chromatin structure, neuronal transcription, and mouse behavior. We find that H2BE is enriched at promoters and a single unique amino acid allows it to dramatically enhance chromatin accessibility. Lastly, we show that H2BE is critical for synaptic gene expression and long-term memory. Together, these data reveal a novel mechanism linking histone variants to chromatin regulation, neuronal function, and memory. This work further identifies the first widely expressed H2B variant and uncovers a single histone amino acid with profound effects on genomic structure.

genetics↗